Bangxian Tan

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Yifeng Bai, Vivek Verma et al. · JNCI Journal of the National Cancer Institute · 2022 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial

Hongru Yang, Xin Chen, Sheng Lin et al. · Radiotherapy and Oncology · 2017 · 104 citations

Medicine, Oncology, Radiation Oncology +11

Concurrent three-dimensional conformal radiotherapy and chemotherapy for postoperative recurrence of mediastinal lymph node metastases in patients with esophageal squamous cell carcinoma: a phase 2 single-institution study

Daiyuan Ma, Bangxian Tan, Mi Liu et al. · Radiation Oncology · 2014 · 39 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial

Xiang Li, Jinfeng Rong, Xinchen et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 33 citations

Medicine, Oncology, Radiation Oncology +17

Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial

Congying Xie, Jing Zhao, Honglei Luo et al. · British Journal of Cancer · 2020 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +15